封面
市場調查報告書
商品編碼
2055291

造影劑市場:按類型、影像方法、應用、給藥途徑、最終用戶和地區分類。

Contrast Media Market, By Type, By Imaging Technique, By Application, By Route of Administration, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,造影市場規模將達到68.8億美元,到2033年將達到120.2億美元。預計從2026年到2033年,其複合年成長率將達到8.3%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 68.8億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 8.30% 2033年市場規模預測: 120.2億美元

全球造影劑市場是醫學影像產業的重要組成部分,其中包括旨在增強診斷影像檢查中內部結構可見性的特殊藥物。造影劑(也稱為造影劑或造影染料)用於接受各種影像檢查的患者,例如電腦斷層掃描 (CT)、超音波磁振造影(MRI)、超音波和 X 光檢查,有助於提高診斷準確性和臨床療效。

該市場涵蓋多種造影劑,包括碘基、钆造影、鋇基化合物和微氣泡造影造影,旨在滿足特定的造影應用和患者需求。慢性病盛行率的上升、人口老化以及醫療影像設備的科技進步推動了全球對先進造影劑的需求。該市場的特點是配方化學、安全性以及靶向成像應用方面的持續創新,其驅動力在於提高診斷準確性並最大限度減少副作用。領先的市場參與企業致力於開發具有更高生物相容性、更低腎毒性和更強成像能力的下一代造影劑,以滿足全球不同醫療機構不斷變化的臨床需求和監管標準。

市場動態

全球造影劑市場的成長主要受幾個關鍵因素驅動,這些因素共同支撐著該市場在國際醫療保健體系中持續成長。心血管疾病、癌症和神經系統疾病發病率的不斷上升,使得先進的診斷影像檢查技術需求日益成長,從而帶動了對能夠精確顯示解剖結構和疾病狀態的高品質造影劑的需求。醫療影像設備的科技進步,包括高解析度CT掃描儀、先進MRI系統和先進超音波設備,為開發能夠提升造影能力的改良型造影劑配方創造了機會。

全球老化是成長要素的重要因素,因為老年患者需要更頻繁地進行影像檢查,以進行慢性病管理和預防性健康篩檢。然而,市場也面臨許多阻礙因素。特別是對於需要大規模臨床試驗和安全性評估的新型造影劑而言,嚴格的監管核准流程可能導致產品上市延遲和研發成本增加。與造影造影相關的腎臟病、過敏反應和腎源性系統性纖維化等安全問題,對市場擴張構成挑戰,並導致醫療專業人員和患者對其使用持謹慎態度。儘管存在這些限制因素,但開發中國家醫療基礎設施的不斷完善、醫療成本的上漲、人們對早期疾病檢測意識的提高以及能夠提供靶向成像解決方案的器官特異性造影劑的研發,都帶來了巨大的市場機會。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數創建了全球造影劑市場主要公司的概況:公司亮點、產品系列、關鍵亮點、財務表現和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球造影劑市場報告的目標受群眾外包括產業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球造影劑市場分析中使用的各種策略矩陣,更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 促進因素
  • 抑制因子
  • 機會
  • 影響分析
  • 主要進展
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景
  • 產業趨勢

第4章 全球造影劑市場:依類型分類,2021-2033年

  • 碘基造影劑
  • 單體型碘造影劑
  • 二聚碘造影劑
  • 钆基造影劑(GBCM)
  • 鋇基造影劑
  • 其他(微氣泡造影劑)

第5章 全球造影劑市場:依影像方法分類,2021-2033年

  • X光/電腦斷層掃描(CT)
  • 磁振造影(MRI)
  • 超音波影像
  • 透視
  • 其他(血管造影術)

第6章 全球造影,2021-2033年

  • 心血管系統
  • 腫瘤學
  • 神經病學
  • 消化器官系統
  • 肌肉骨骼系統
  • 泌尿系統
  • 感染疾病
  • 其他治療領域

第7章 全球造影劑市場:依給藥途徑分類,2021-2033年

  • 口服
  • 直腸
  • 靜脈

第8章 全球造影劑市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診斷中心
  • 診斷影像中心
  • 門診手術中心
  • 其他(研究和學術機構)

第9章 全球造影劑市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第10章 競爭格局

  • GE Healthcare
  • Bayer AG
  • Bracco Imaging
  • Siemens Healthineers
  • Fujifilm Holdings Corporation
  • Philips Healthcare
  • Guerbet Group
  • Mallinckrodt Pharmaceuticals
  • Canon Medical Systems
  • Hologic, Inc.
  • Lantheus Medical Imaging
  • COVIDIEN(Medtronic)
  • Esaote SpA
  • Shimadzu Corporation
  • Hughes Medical Systems

第11章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第12章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI8350

Contrast Media Market is estimated to be valued at USD 6.88 Bn in 2026 and is expected to reach USD 12.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 6.88 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 8.30% 2033 Value Projection: USD 12.02 Bn

The global contrast media market represents a critical segment within the broader medical imaging industry, encompassing specialized pharmaceutical agents designed to enhance the visibility of internal body structures during diagnostic imaging procedures. These contrast agents, also known as contrast materials or contrast dyes, are administered to patients undergoing various imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and X-ray examinations to improve diagnostic accuracy and clinical outcomes.

The market comprises different types of contrast media, including iodinated contrast agents, gadolinium-based contrast agents, barium-based compounds, and microbubble contrast agents, each tailored for specific imaging applications and patient requirements. With the increasing prevalence of chronic diseases, aging population demographics, and technological advancements in medical imaging equipment, the demand for sophisticated contrast media solutions continues to expand globally. The market is characterized by continuous innovation in formulation chemistry, safety profiles, and targeted imaging applications, driven by the need for enhanced diagnostic precision while minimizing adverse reactions. Key market participants focus on developing next-generation contrast agents with improved biocompatibility, reduced nephrotoxicity, and enhanced imaging capabilities to meet evolving clinical demands and regulatory standards across diverse healthcare settings worldwide.

Market Dynamics

The global contrast media market growth is primarily driven by several key factors that collectively fuel its sustained growth trajectory across international healthcare systems. The increasing incidence of cardiovascular diseases, cancer, and neurological disorders necessitates advanced diagnostic imaging procedures, thereby boosting demand for high-quality contrast agents that enable precise visualization of anatomical structures and pathological conditions. Technological advancements in medical imaging equipment, including the development of high-resolution CT scanners, advanced MRI systems, and sophisticated ultrasound devices, create opportunities for enhanced contrast media formulations that can capitalize on improved imaging capabilities.

The aging global population represents a significant growth driver, as elderly patients require more frequent diagnostic imaging procedures for chronic disease management and preventive healthcare screening programs. However, the market faces notable restraints including stringent regulatory approval processes that can delay product launches and increase development costs, particularly for novel contrast agent formulations requiring extensive clinical trials and safety evaluations. Safety concerns related to contrast-induced nephropathy, allergic reactions, and nephrogenic systemic fibrosis associated with certain contrast agents pose challenges for market expansion, leading to cautious adoption patterns among healthcare providers and patients. Despite these constraints, substantial opportunities emerge from expanding healthcare infrastructure in developing economies, increasing healthcare expenditure, growing awareness about early disease detection, and the development of organ-specific contrast agents that offer targeted imaging solutions.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global contrast media market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include GE Healthcare, Bayer AG, Bracco Imaging, Siemens Healthineers, Fujifilm Holdings Corporation, Philips Healthcare, Guerbet Group, Mallinckrodt Pharmaceuticals, Canon Medical Systems, Hologic, Inc., Lantheus Medical Imaging, COVIDIEN (Medtronic), Esaote S.p.A., Shimadzu Corporation, and Hughes Medical Systems.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global contrast media market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contrast media market.

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Iodinated Contrast Media
  • Monomeric Iodinated Contrast Media
  • Dimeric Iodinated Contrast Media
  • Gadolinium-Based Contrast Media (GBCM)
  • Barium-Based Contrast Media
  • Others (Microbubble Contrast Media)
  • Imaging Technique Insights (Revenue, USD Bn, 2021 - 2033)
  • X-ray/Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound Imaging
  • Fluoroscopy
  • Others (Angiography)
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Cardiovascular
  • Oncology
  • Neurology
  • Gastrointestinal
  • Musculoskeletal
  • Pulmonary
  • Urology
  • Infectious Diseases
  • Other Therapeutic Areas
  • Route Of Administration Insights (Revenue, USD Bn, 2021 - 2033)
  • Oral
  • Rectal
  • Intravenous
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Diagnostic Centers
  • Imaging Centers
  • Ambulatory Surgical Centers
  • Others (Research and Academic Institutes)
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • GE Healthcare
  • Bayer AG
  • Bracco Imaging
  • Siemens Healthineers
  • Fujifilm Holdings Corporation
  • Philips Healthcare
  • Guerbet Group
  • Mallinckrodt Pharmaceuticals
  • Canon Medical Systems
  • Hologic, Inc.
  • Lantheus Medical Imaging
  • COVIDIEN (Medtronic)
  • Esaote S.p.A.
  • Shimadzu Corporation
  • Hughes Medical Systems

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Contrast Media Market, By Type
    • Global Contrast Media Market, By Imaging Technique
    • Global Contrast Media Market, By Application
    • Global Contrast Media Market, By Route of Administration
    • Global Contrast Media Market, By End User
    • Global Contrast Media Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Contrast Media Market, By Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Monomeric Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Dimeric Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Gadolinium-Based Contrast Media (GBCM)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Barium-Based Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others (Microbubble Contrast Media)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Contrast Media Market, By Imaging Technique, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • X-ray/Computed Tomography (CT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Magnetic Resonance Imaging (MRI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ultrasound Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Fluoroscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others (Angiography)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Contrast Media Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Gastrointestinal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Musculoskeletal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pulmonary
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Urology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Other Therapeutic Areas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Contrast Media Market, By Route of Administration, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Rectal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Contrast Media Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Imaging Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others (Research and Academic Institutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Contrast Media Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bracco Imaging
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fujifilm Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Guerbet Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mallinckrodt Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Canon Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lantheus Medical Imaging
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • COVIDIEN (Medtronic)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Esaote S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Shimadzu Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hughes Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us